Serum CA 125, CA 15-3, CEA, and CA 19-9: a prognostic factor for uterine carcinosarcomas?

被引：0
|
作者：
Nikolaos Thomakos
Alexandros Rodolakis
Flora Zagouri
Dimitrios Zacharakis
Maria Sotiropoulou
Nikolaos Akrivos
Dimitrios Haidopoulos
Christos A. Papadimitriou
Meletios-Athanassios Dimopoulos
Aris Antsaklis
机构：
[1] University of Athens,Department of Obstetrics and Gynecology, Alexandra Hospital, School of Medicine
[2] University of Athens,Department of Clinical and Therapeutics, Alexandra Hospital, School of Medicine
[3] Alexandra Hospital,Department of Pathology
来源：
Archives of Gynecology and Obstetrics | 2013年 / 287卷
关键词：
CEA; CA 125; CA 19-9; CA 15-3; Serum; Uterine carcinosarcoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：97 / 102
页数：5
相关论文
共 50 条
  • [31] The assessment of biliary CA 125, CA 19-9 and CEA in diagnosing cholangiocarcinoma - The influence of sampling time and hepatolithiasis
    Chen, CY
    Shiesh, SC
    Tsao, HC
    Lin, XZ
    HEPATO-GASTROENTEROLOGY, 2002, 49 (45) : 616 - 620
  • [32] Serum CEA, CA125, CA19-9, and CA724 levels for the diagnosis and staging of cholangiocarcinoma.
    Deng, Yawen
    Zhong, Rihui
    Xie, Xiaoying
    Xiong, Xuxia
    He, Jian
    Peng, Linhui
    Zeng, Hua
    Duan, Chaohui
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (03): : 1413 - 1418
  • [33] CEA, CA 19-9, and CA-50 in monitoring gastric carcinoma
    Pectasides, D
    Mylonakis, A
    Kostopoulou, M
    Papadopoulou, M
    Triantafillis, D
    Varthalitis, J
    Dimitriades, M
    Athanassiou, A
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1997, 20 (04): : 348 - 353
  • [34] Comparison of the clinical value of CA 19-9 versus CA 125 for the diagnosis of endometriosis
    Kurdoglu, Zehra
    Gursoy, Rifat
    Kurdoglu, Mertihan
    Erdem, Mehmet
    Erdem, Ozlem
    Erdem, Ahmet
    FERTILITY AND STERILITY, 2009, 92 (05) : 1761 - 1763
  • [35] Analytical performance and clinical concordance of the cancer biomarkers CA 15-3, CA 19-9, CA 125 II, Carcinoembryonic Antigen, and Alpha-Fetoprotein on the Dimension Vista® System
    Christenson, Robert H.
    Cervelli, Denise R.
    Sterner, Jamie
    Bachmann, Lauren M.
    Rebuck, Heather
    Gray, Jeffery
    Kelley, Walter E.
    CLINICAL BIOCHEMISTRY, 2011, 44 (13) : 1128 - 1136
  • [36] The diagnostic value of serum tumor markers CEA, CA19-9, CA125, CA15-3, and TPS in metastatic breast cancer
    Wang, Weigang
    Xu, Xiaoqin
    Tian, Baoguo
    Wang, Yan
    Du, Lili
    Sun, Ting
    Shi, Yanchun
    Zhao, Xianwen
    Jing, Jiexian
    CLINICA CHIMICA ACTA, 2017, 470 : 51 - 55
  • [37] Serum CEA and CA 19-9 Levels are Associated with the Presence and Severity of Colorectal Neoplasia
    Kim, Nam Hee
    Lee, Mi Yeon
    Park, Jung Ho
    Park, Dong Il
    Sohn, Chong Il
    Choi, Kyuyong
    Jung, Yoon Suk
    YONSEI MEDICAL JOURNAL, 2017, 58 (05) : 918 - 924
  • [38] CEA、CA19-9、CA125和CA15-3联合检测用于恶性肿瘤诊断
    严桂风
    临床检验杂志, 1998, (06) : 54 - 55
  • [39] Mammary serum antigen (MSA), Ca 549, CA 15-3 and CEA in breast cancer preoperative sensitivity and correlation to prognostic factors
    Heinze, T
    Schurenkamper, P
    Minguillon, C
    Lichtenegger, W
    ANTICANCER RESEARCH, 1997, 17 (4B) : 2953 - 2954
  • [40] Diagnostic role of tumour markers CEA, CA15-3, CA19-9 and CA125 in lung cancer
    Ghosh I.
    Bhattacharjee D.
    Das A.K.
    Chakrabarti G.
    Dasgupta A.
    Dey S.K.
    Indian Journal of Clinical Biochemistry, 2013, 28 (1) : 24 - 29
12345